CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Daewon Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Daewon Pharmaceutical Co Ltd
386, Cheonho-daero, Seongdong-gu
Phone: +82 222047000p:+82 222047000 SEOUL, 04808  South Korea Ticker: 003220003220
Business Summary
Daewon Pharmaceutical Co Ltd is a Korea-based holding company primarily engaged in the manufacturing and sales of pharmaceuticals business. The Company operates its business through four segments. The Pharmaceutical segment is mainly engaged in the manufacturing and sales of drugs such as Jinhae expectant, antipyretic analgesic, antidote and arteriosclerotic agents. The Cosmetics segment is mainly engaged in the manufacturing and sales of cosmetics such as mask packs and eye patches, which are used for moisturizing the skin. The Health Functional Food segment is mainly engaged in the manufacturing and sales of health functional foods. The Other segment is mainly engaged in the supply of other goods and service services. The Company sells its products in domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2844 Perfumes, cosmetics, and other toilet preparations
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Co-Chief Executive Officer, Director InBaek 41 1/19/2024 3/25/2022
Co-President Tae HongChoi 66
Co-President Byeong HoYoon 72
10 additional Officers and Directors records available in full report.

Business Names
Business Name
003220
Daewon Pharmaceutical Company

General Information
Number of Employees: 738 (As of 3/31/2016)
Outstanding Shares: 21,433,439 (As of 9/30/2025)
Shareholders: 21,306
Stock Exchange: KRX
Fax Number: +82 234364878


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 21, 2025